2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
- PMID: 26320113
- DOI: 10.1093/eurheartj/ehv317
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
Keywords: Chronic thromboembolic pulmonary hypertension; Congenital heart disease; Connective tissue disease; Endothelin receptor antagonists; Guidelines; Heart failure; Left heart disease; Lung disease; Phosphodiesterase type 5 inhibitors; Prostacyclin analogues; Pulmonary arterial hypertension; Pulmonary hypertension; Respiratory failure.
Comment in
-
What's new in the European Society of Cardiology/European Respiratory Society Pulmonary Hypertension Guidelines?Eur Heart J. 2016 Jan 1;37(1):4-5. doi: 10.1093/eurheartj/ehv636. Eur Heart J. 2016. PMID: 26712889 No abstract available.
-
The Ten Commandments for 2015 European Society of Cardiology–European Respiratory Society Guidelines on Pulmonary Hypertension.Eur Heart J. 2016 Jan 1;37(1):5. Eur Heart J. 2016. PMID: 27099879 No abstract available.
Similar articles
-
Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).Eur Heart J. 2009 Oct;30(20):2493-537. doi: 10.1093/eurheartj/ehp297. Epub 2009 Aug 27. Eur Heart J. 2009. PMID: 19713419 No abstract available.
-
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).Eur Respir J. 2015 Oct;46(4):903-75. doi: 10.1183/13993003.01032-2015. Epub 2015 Aug 29. Eur Respir J. 2015. PMID: 26318161
-
Diagnostics, monitoring and outpatient care in children with suspected pulmonary hypertension/paediatric pulmonary hypertensive vascular disease. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.Heart. 2016 May;102 Suppl 2:ii1-13. doi: 10.1136/heartjnl-2015-307792. Heart. 2016. PMID: 27053692
-
[Pulmonary arterial hypertension associated with common diseases: connective-tissue diseases, HIV infection and portal hypertension].Rev Prat. 2008 Nov 30;58(18):2011-8. Rev Prat. 2008. PMID: 19143272 Review. French.
-
[Pulmonary arterial hypertension associated with connective tissue diseases].Presse Med. 2014 Sep;43(9):957-69. doi: 10.1016/j.lpm.2014.07.009. Epub 2014 Aug 14. Presse Med. 2014. PMID: 25129118 Review. French.
Cited by
-
The Transcription Factor C/EBPβ Promotes HFL-1 Cell Migration, Proliferation, and Inflammation by Activating lncRNA HAS2-AS1 in Hypoxia.Front Cell Dev Biol. 2021 Mar 12;9:651913. doi: 10.3389/fcell.2021.651913. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33777961 Free PMC article.
-
Direct oral anticoagulants in chronic thromboembolic pulmonary hypertension.J Thromb Thrombolysis. 2021 Oct;52(3):791-796. doi: 10.1007/s11239-021-02445-z. Epub 2021 Apr 9. J Thromb Thrombolysis. 2021. PMID: 33835334 Review.
-
Inhibition of heterogeneous nuclear ribonucleoproteins A1 and oxidative stress reduces glycolysis via pyruvate kinase M2 in chronic thromboembolic pulmonary hypertension.J Transl Int Med. 2023 Mar 19;12(4):437-451. doi: 10.2478/jtim-2022-0051. eCollection 2024 Sep. J Transl Int Med. 2023. PMID: 39360158 Free PMC article.
-
The original and two new derivative versions of the COMPERA 2.0 risk assessment model: useful tools for guiding balloon pulmonary angioplasty.Respir Res. 2022 Nov 15;23(1):312. doi: 10.1186/s12931-022-02232-1. Respir Res. 2022. PMID: 36376902 Free PMC article.
-
Impact of borderline pulmonary hypertension due to left heart failure on mortality in a multicenter registry study: A 3-year survivorship analysis.Front Cardiovasc Med. 2022 Aug 12;9:983803. doi: 10.3389/fcvm.2022.983803. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36035936 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical